A detailed history of Benjamin Edwards Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 381,749 shares of MRK stock, worth $37.7 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
381,749
Previous 28,057 1260.62%
Holding current value
$37.7 Million
Previous $3.47 Million 1148.23%
% of portfolio
0.65%
Previous 0.67%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $39.3 Million - $45.6 Million
353,692 Added 1260.62%
381,749 $43.4 Million
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $32,683 - $35,101
264 Added 0.95%
28,057 $3.47 Million
Q1 2024

Apr 29, 2024

SELL
$113.24 - $131.95 $267,133 - $311,270
-2,359 Reduced 7.82%
27,793 $3.67 Million
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $8,615 - $9,375
-86 Reduced 0.28%
30,152 $3.29 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $241,829 - $268,561
-2,349 Reduced 7.21%
30,238 $3.11 Million
Q2 2023

Aug 15, 2023

SELL
$108.61 - $118.38 $450,514 - $491,040
-4,148 Reduced 11.29%
32,587 $3.76 Million
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $336,202 - $375,132
-3,266 Reduced 8.16%
36,735 $3.91 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $364,012 - $466,713
4,163 Added 11.62%
40,001 $4.44 Million
Q3 2022

Oct 28, 2022

BUY
$84.53 - $94.96 $116,735 - $131,139
1,381 Added 4.01%
35,838 $3.09 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $380,714 - $431,558
4,560 Added 15.25%
34,457 $3.14 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $450,395 - $504,864
6,127 Added 25.78%
29,897 $2.45 Million
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $666,493 - $834,869
9,221 Added 63.38%
23,770 $1.82 Million
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $447,569 - $492,214
6,244 Added 75.18%
14,549 $1.09 Million
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $62,435 - $69,059
-888 Reduced 9.66%
8,305 $646,000
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $31,331 - $36,905
455 Added 5.21%
9,193 $709,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $20,382 - $22,620
284 Added 3.36%
8,738 $715,000
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $34,906 - $39,567
477 Added 5.98%
8,454 $701,000
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $24,928 - $28,366
-354 Reduced 4.25%
7,977 $617,000
Q1 2020

May 07, 2020

BUY
$63.36 - $87.82 $401,955 - $557,130
6,344 Added 319.28%
8,331 $641,000
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $6,516 - $7,353
84 Added 4.41%
1,987 $181,000
Q3 2019

Nov 05, 2019

BUY
$76.08 - $82.93 $21,226 - $23,137
279 Added 17.18%
1,903 $160,000
Q2 2019

Aug 08, 2019

BUY
$69.84 - $81.59 $19,415 - $22,682
278 Added 20.65%
1,624 $136,000
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $93,654 - $106,818
1,346 New
1,346 $112,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.